HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Controversy Around Nano Not All Cleared Up By Friends Of The Earth Guide

This article was originally published in The Rose Sheet

Executive Summary

A newly issued "consumer guide" from Friends of the Earth (FOE) may serve only to complicate the issue of nanotechnology in personal-care products for consumers faced with an absence of consensus among industry, public interest groups and other stakeholders

You may also be interested in...



Report Contests “Unsubstantiated” Nanotech Concerns, Touts Nano-Sunscreen

Current evidence suggests that nano-sized cosmetic ingredients pose no more risk to human health than their macro-sized counterparts, L'Oréal researchers maintain in a review published this month in Skin Pharmacology and Physiology

Report Contests “Unsubstantiated” Nanotech Concerns, Touts Nano-Sunscreen

Current evidence suggests that nano-sized cosmetic ingredients pose no more risk to human health than their macro-sized counterparts, L'Oréal researchers maintain in a review published this month in Skin Pharmacology and Physiology

Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition

FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate the formulas "new drugs," a coalition of public interest groups states in a citizen petition

Related Content

UsernamePublicRestriction

Register

RS014914

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel